AAD VMX 2021: Real-World Data Demonstrate Ongoing Dupilumab Efficacy in Atopic Dermatitis
Interim registry results from more than 300 adult patients over 6 months in North America were reported
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.